Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BALCHEM CORPBCPC · Entity 3839 | Director · Chairman, President & CEO | February 11, 2026 | February 13, 2026 |
| PENTAIR plcPNR · Entity 3537 | Director | January 02, 2026 | January 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BALCHEM CORP
Report date February 11, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,373 |
Ending reported balance
After 2026-02-12 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-02-11 · Grant · Acquired 7,350 · Balance 83,284 F1: Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Row 2 · 2026-02-11 · Grant · Acquired 18,291 · Balance 101,575 F2: Represents the vesting of performance stock units (includes 306 dividend equivalent shares) for the 2023-2025 performance period. Row 3 · 2026-02-11 · Tax withholding · Disposed 9,358 · Balance 92,217 F3: 9,358 of the 18,291 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting. Row 4 · 2026-02-12 · Tax withholding · Disposed 844 · Balance 91,373 F4: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025). |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $178.68 · Expires 2036-02-11 | Direct | 26,900 |
Reported balance
After 2026-02-11 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-02-11 · Grant · Acquired 26,900 · Balance 26,900 F6: Options vest 20% Year 1, 40% Year 2, and 40% Year 3. |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 2,007 |
Reported balance
Holding disclosure · report date 2026-02-11 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 2,007 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 1,022.58 |
Reported balance
Holding disclosure · report date 2026-02-11 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 1,022.58 F5: Reflects securities held in a trust for the benefit of the Reporting Person's mother and for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership over the securities held by the trust, except to the extent of his pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2: Represents the vesting of performance stock units (includes 306 dividend equivalent shares) for the 2023-2025 performance period.
F3: 9,358 of the 18,291 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting.
F4: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025).
F5: Reflects securities held in a trust for the benefit of the Reporting Person's mother and for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership over the securities held by the trust, except to the extent of his pecuniary interest therein, if any.
F6: Options vest 20% Year 1, 40% Year 2, and 40% Year 3.
PENTAIR plc
Report date January 02, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock - Restricted Stock UnitsSEC Table I · non-derivative | Direct | 1,564 |
Reported balance
After 2026-01-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-01-02 · Grant · Acquired 1,564 · Balance 1,564 F1: Restricted stock units granted pursuant to and subject to a vesting condition of the Pentair plc 2020 Share and Incentive Plan. Each restricted stock unit represents a right to receive one Pentair plc share upon vesting. F2: End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a). F3: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. |
| Common StockSEC Table I · non-derivative | Direct | 15,347 |
Reported balance
After 2026-01-02 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-01-02 · Tax withholding · Disposed 689 · Balance 15,347 F4: Shares surrendered to pay taxes applicable to vesting of restricted stock units. F3: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units granted pursuant to and subject to a vesting condition of the Pentair plc 2020 Share and Incentive Plan. Each restricted stock unit represents a right to receive one Pentair plc share upon vesting.
F2: End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a).
F3: End-of-period holdings reflect the vesting of restricted stock units that were previously reported.
F4: Shares surrendered to pay taxes applicable to vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2026 Filed Feb 13, 2026 23:51 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 844 | $177.49 | $149,801.56 |
DisclosureSEC source: 0001140361-26-005536 · form4.xml · nonDerivative · entry 4 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,373 F4 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025). Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 23:51 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 26,900 | $0.00 Strike: $178.68 | $0.00 |
DisclosureSEC source: 0001140361-26-005536 · form4.xml · derivative · entry 7 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,900 Underlying: Common Stock · 26,900 shares Expires 2036-02-11 F6 · derivative.exercise_date: Options vest 20% Year 1, 40% Year 2, and 40% Year 3. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 23:51 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 9,358 | $178.68 | $1,672,087.44 |
DisclosureSEC source: 0001140361-26-005536 · form4.xml · nonDerivative · entry 3 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,217 F3 · shares: 9,358 of the 18,291 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 23:51 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 18,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-005536 · form4.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,575 F2 · shares: Represents the vesting of performance stock units (includes 306 dividend equivalent shares) for the 2023-2025 performance period. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 23:51 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 7,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-005536 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,284 F1 · shares: Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 21:28 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 3,225 | $173.16 | $558,441.00 |
DisclosureSEC source: 0001140361-26-004617 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,934 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/8/2023). Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:32 UTC | PENTAIR plc PNR · Entity 3537 | Tax withholdingCommon Stock | 689 | $105.47 | $72,668.83 |
DisclosureSEC source: 0000897069-26-000068 · form4.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,347 F4 · kind: Shares surrendered to pay taxes applicable to vesting of restricted stock units. F3 · balance_after: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:32 UTC | PENTAIR plc PNR · Entity 3537 | GrantCommon Stock - Restricted Stock Units | 1,564 | $0.00 | $0.00 |
DisclosureSEC source: 0000897069-26-000068 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,564 F1 · kind: Restricted stock units granted pursuant to and subject to a vesting condition of the Pentair plc 2020 Share and Incentive Plan. Each restricted stock unit represents a right to receive one Pentair plc share upon vesting. F2 · balance_after: End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a). F3 · balance_after: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 22:44 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 11,442 | $163.14 | $1,866,647.88 |
DisclosureSEC source: 0001140361-25-004914 · form4.xml · nonDerivative · entry 3 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,159 F3 · shares: 11,442 of 22,364 the performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 22:44 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 22,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-004914 · form4.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,601 F2 · shares: Represents the vesting of performance stock units (includes 369 dividend equivalent shares) for the 2022-2024 performance period. Read SEC document |
| February 13, 2025 Filed Apr 11, 2025 22:08 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 11,442 | $163.14 | $1,866,647.88 |
DisclosureSEC source: 0001140361-25-013553 · form4.xml · nonDerivative · entry 3 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,159 F3 · shares: 11,442 of 22,364 the performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 13, 2025 Filed Apr 11, 2025 22:08 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 22,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-013553 · form4.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,601 F2 · shares: Represents the vesting of performance stock units (includes 369 dividend equivalent shares) for the 2022-2024 performance period. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:44 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 21,500 | $0.00 Strike: $159.18 | $0.00 |
DisclosureSEC source: 0001140361-25-004914 · form4.xml · derivative · entry 5 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,500 Underlying: Common Stock · 21,500 shares Expires 2035-02-12 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:44 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 6,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-004914 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,237 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 12, 2025 Filed Apr 11, 2025 22:08 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 21,500 | $0.00 Strike: $159.18 | $0.00 |
DisclosureSEC source: 0001140361-25-013553 · form4.xml · derivative · entry 5 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,500 Underlying: Common Stock · 21,500 shares Expires 2035-02-12 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 12, 2025 Filed Apr 11, 2025 22:08 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 6,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-013553 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,237 F1 · shares: Ownership of restricted stock vests in Reporting Person ratably over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 23:18 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 3,071 | $159.39 | $489,486.69 |
DisclosureSEC source: 0001140361-25-004099 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,637 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/10/2022). Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:15 UTC | PENTAIR plc PNR · Entity 3537 | Tax withholdingCommon Stock | 963 | $100.40 | $96,685.20 |
DisclosureSEC source: 0000897069-25-000073 · form4.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,376 F4 · kind: Shares surrendered to pay taxes applicable to vesting of restricted stock units. F3 · balance_after: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:15 UTC | PENTAIR plc PNR · Entity 3537 | GrantCommon Stock - Restricted Stock Units | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0000897069-25-000073 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,643 F1 · kind: Restricted stock units granted pursuant to and subject to a vesting condition of the Pentair plc 2020 Share and Incentive Plan. Each restricted stock unit represents a right to receive one Pentair plc share upon vesting. F2 · balance_after: End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a). F3 · balance_after: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:37 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionStock Options (right to buy) · Derivative | 24,350 | $0.00 Strike: $60.85 | $0.00 |
DisclosureSEC source: 0001140361-24-009271 · form4.xml · derivative · entry 11 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,350 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Stock options that vested 20% on February 23, 2017, 40% on February 23, 2018, and 40% on February 23, 2019, and are exercisable. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:37 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionStock Options (right to buy) · Derivative | 10,000 | $0.00 Strike: $54.87 | $0.00 |
DisclosureSEC source: 0001140361-24-009271 · form4.xml · derivative · entry 10 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2025-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Stock options that vested 20% on April 28, 2016, 40% on April 28, 2017, and 40% on April 28, 2018, and are exercisable. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:37 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 5,864 | $155.25 | $910,380.14 |
DisclosureSEC source: 0001140361-24-009271 · form4.xml · nonDerivative · entry 9 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,412 F7 · price: This transaction was executed in multiple sales ranging from $155.0800 to $155.5700 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:37 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 13,989 | $154.66 | $2,163,538.74 |
DisclosureSEC source: 0001140361-24-009271 · form4.xml · nonDerivative · entry 8 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,276 F6 · price: This transaction was executed in multiple sales ranging from $154.0800 to $155.0750 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:37 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 14,497 | $153.56 | $2,226,107.13 |
DisclosureSEC source: 0001140361-24-009271 · form4.xml · nonDerivative · entry 7 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,265 F5 · price: This transaction was executed in multiple sales ranging from $153.0800 to $154.0775 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:37 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 24,350 | $60.85 | $1,481,697.50 |
DisclosureSEC source: 0001140361-24-009271 · form4.xml · nonDerivative · entry 6 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:37 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 10,000 | $54.87 | $548,700.00 |
DisclosureSEC source: 0001140361-24-009271 · form4.xml · nonDerivative · entry 5 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:37 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 200 | $155.91 | $31,182.00 |
DisclosureSEC source: 0001140361-24-009271 · form4.xml · nonDerivative · entry 4 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,412 Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:37 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 2,667 | $154.84 | $412,947.35 |
DisclosureSEC source: 0001140361-24-009271 · form4.xml · nonDerivative · entry 3 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,612 F3 · price: This transaction was executed in multiples sales ranging from $154.4700 to $155.3800 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:37 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 16,015 | $153.75 | $2,462,243.79 |
DisclosureSEC source: 0001140361-24-009271 · form4.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,279 F2 · price: This transaction was executed in multiples sales ranging from $153.3400 to $154.2900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:37 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 10,797 | $152.97 | $1,651,658.12 |
DisclosureSEC source: 0001140361-24-009271 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,294 F1 · price: This transaction was executed in multiples sales ranging from $152.3350 to $153.3200 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| February 11, 2024 Filed Feb 14, 2024 00:09 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 3,452 | $145.33 | $501,679.16 |
DisclosureSEC source: 0001140361-24-007572 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,091 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/11/2021) Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:42 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 21,500 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007121 · form4.xml · derivative · entry 4 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,500 Underlying: Common Stock · 21,500 shares Expires 2034-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:42 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 11,768 | $143.43 | $1,687,884.24 |
DisclosureSEC source: 0001140361-24-007121 · form4.xml · nonDerivative · entry 3 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,543 F4 · shares: 11,768 of the 20,639 performance stock units that vested on February 8, 2024 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:42 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 20,639 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007121 · form4.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,311 F3 · shares: Represents the vesting of performance stock units (includes 316 dividend equivalent shares) for the 2021-2023 performance period. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:42 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 6,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007121 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,672 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 01:20 UTC | PENTAIR plc PNR · Entity 3537 | Tax withholdingCommon Stock | 1,334 | $68.28 | $91,085.52 |
DisclosureSEC source: 0000897069-24-000100 · form4.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,057 F4 · kind: Shares surrendered to pay taxes applicable to vesting of restricted stock units. F3 · balance_after: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. Read SEC document |
| January 02, 2024 Filed Jan 5, 2024 01:20 UTC | PENTAIR plc PNR · Entity 3537 | GrantCommon Stock - Restricted Stock Units | 2,256 | $0.00 | $0.00 |
DisclosureSEC source: 0000897069-24-000100 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,256 F1 · kind: Restricted stock units granted pursuant to and subject to a vesting condition of the Pentair plc 2020 Share and Incentive Plan. Each restricted stock unit represents a right to receive one Pentair plc share upon vesting. F2 · balance_after: End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a). F3 · balance_after: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:15 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 2,568 | $135.67 | $348,400.56 |
DisclosureSEC source: 0001140361-23-007246 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,897 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/13/2020). Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 21,200 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006114 · form4.xml · derivative · entry 4 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,200 Underlying: Common Stock · 21,200 shares Expires 2033-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 8,864 | $138.09 | $1,224,029.76 |
DisclosureSEC source: 0001140361-23-006114 · form4.xml · nonDerivative · entry 3 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,465 F4 · shares: 8,864 of the 17,344 performance stock units that vested on February 8, 2023 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 17,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006114 · form4.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,329 F3 · shares: Represents the vesting of performance stock units (includes 256 dividend equivalent shares) for the 2020-2022 performance period. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 6,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006114 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,985 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 23:39 UTC | PENTAIR plc PNR · Entity 3537 | Tax withholdingCommon Shares | 753 | $45.20 | $34,035.60 |
DisclosureSEC source: 0001567619-23-000343 · doc1.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,024 F4 · kind: Shares surrendered to pay taxes applicable to vesting of restricted stock units. F3 · balance_after: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 23:39 UTC | PENTAIR plc PNR · Entity 3537 | GrantCommon Shares - Restricted Stock Units | 3,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-000343 · doc1.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,319 F1 · kind: Restricted stock units granted pursuant to and subject to a vesting condition of the Pentair plc 2020 Share and Incentive Plan. Each restricted stock unit represents a right to receive one Pentair plc share upon vesting. F2 · balance_after: End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a). F3 · balance_after: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 20:16 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option (Right to Buy) · Derivative | 130,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-033779 · form4.xml · derivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2032-09-15 F1 · derivative.exercise_price: The stock options grant is structured in four tranches with increasing exercise prices as follows: (a) 25% at fair market value as of grant date of $125.71; (b) 25% at $125.71 plus 10% premium; (c) 25% at $125.71 plus 15% premium; and (d) 25% at $125.71 plus 20% premium. F2 · derivative.exercise_date: The stock options vest over a five-year period with: (a) 25% vesting on 9/15/2025; (b) 25% vesting on 9/15/2026; and (c) 50% vesting on 9/15/2027. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 19:46 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 2,400 | $139.38 | $334,512.00 |
DisclosureSEC source: 0001140361-22-005739 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,558 F1 · shares: 2,400 of the 4,700 Restricted Shares (date of grant 02/15/2018) that vested 02/15/2022 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 21:33 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 3,130 | $137.73 | $431,094.90 |
DisclosureSEC source: 0001140361-22-005581 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,958 F1 · shares: 3,130 of the 6,130 Restricted Shares (date of grant 02/13/2019) that vested 02/14/2022 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 13:53 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 20,500 | $0.00 Strike: $138.07 | $0.00 |
DisclosureSEC source: 0001140361-22-005085 · form4.xml · derivative · entry 4 Harris Theodore L · CIK 0001378228 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,280 Underlying: Common Stock · 20,500 shares Expires 2032-02-10 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 13:53 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 8,805 | $138.07 | $1,215,706.35 |
DisclosureSEC source: 0001140361-22-005085 · form4.xml · nonDerivative · entry 3 Harris Theodore L · CIK 0001378228 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,088 F3 · shares: 8,805 of the 17,234 shares that vested February 10, 2022, were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 13:53 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 17,234 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-005085 · form4.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,893 F2 · shares: Acquired upon the settlement of performance shares granted on February 13, 2019, based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period as a result of the satisfaction of those performance criteria. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.